HIT Consultant November 15, 2024
What You Should Know:
– A new report from Strata Decision Technology reveals a significant decline in the number of bariatric surgeries performed in U.S. hospitals in recent years.
– The trend coincides with the rising popularity of weight-loss medications like semaglutide (GLP-1s), which have gained widespread adoption since their approval for chronic weight management.
Declining Surgical Volumes
Strata’s analysis of data from 809 hospitals nationwide shows a clear downward trend in bariatric surgeries. In August 2024, the number of these procedures decreased by over 32% compared to August 2022. This decline corresponds with a substantial increase in semaglutide prescriptions, which jumped over 400% between January 2021 and December 2023, according to a JAMA study.
Impact on Hospital...
Today's Sponsors
Today's Sponsor